FORTIS / Q4-FY24 / risks

Keep the risk register visible.

Fortis Healthcare · Material risks, their source context, and severity in the latest available quarter.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveQ4-FY24 · 2024-05-15Back to quarter ↗

Risk intelligence

Material risks this quarter

Agilus put option liability could strain balance sheet

If PE investor exercises put option, Fortis may need to raise ~₹1,200-1,300 crore, potentially via debt or equity, impacting leverage or dilution.

high

Ongoing legal cases and brand litigation costs

Annual legal costs of ₹30-50 crore related to legacy issues (brand, forensic audit) may persist until resolution; Supreme Court stay on promoter shareholding dismissed.

medium

Diagnostics business recovery slower than expected

Agilus volumes grew only 0.6% in Q4 despite rebranding; competitive pressures and government business provisions may delay margin recovery.

medium

CGHS rate revision uncertainty

Government revenue (20% of hospital) may benefit from CGHS rate revision, but timing and quantum are uncertain; not factored into guidance.

low